Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP682354.RAm5hR2G67FpBGBoIJnKauL1O2-veAItRBgWM8YIMlVKE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP682354.RAm5hR2G67FpBGBoIJnKauL1O2-veAItRBgWM8YIMlVKE130_assertion type Assertion NP682354.RAm5hR2G67FpBGBoIJnKauL1O2-veAItRBgWM8YIMlVKE130_head.
- NP682354.RAm5hR2G67FpBGBoIJnKauL1O2-veAItRBgWM8YIMlVKE130_assertion description "[Three major criteria, saccade amplitude, saccade velocity, and presence of gaze-evoked nystagmus, permitted the correct assignment of 90% of the SCA1, 90% of the SCA2, and 93% of the patients with SCA3 to their genetically confirmed patient group and, therefore, may help orient diagnoses of SCA1, SCA2, and SCA3 at early clinical stages of the diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP682354.RAm5hR2G67FpBGBoIJnKauL1O2-veAItRBgWM8YIMlVKE130_provenance.
- NP682354.RAm5hR2G67FpBGBoIJnKauL1O2-veAItRBgWM8YIMlVKE130_assertion evidence source_evidence_literature NP682354.RAm5hR2G67FpBGBoIJnKauL1O2-veAItRBgWM8YIMlVKE130_provenance.
- NP682354.RAm5hR2G67FpBGBoIJnKauL1O2-veAItRBgWM8YIMlVKE130_assertion SIO_000772 9506545 NP682354.RAm5hR2G67FpBGBoIJnKauL1O2-veAItRBgWM8YIMlVKE130_provenance.
- NP682354.RAm5hR2G67FpBGBoIJnKauL1O2-veAItRBgWM8YIMlVKE130_assertion wasDerivedFrom befree-20140225 NP682354.RAm5hR2G67FpBGBoIJnKauL1O2-veAItRBgWM8YIMlVKE130_provenance.
- NP682354.RAm5hR2G67FpBGBoIJnKauL1O2-veAItRBgWM8YIMlVKE130_assertion wasGeneratedBy ECO_0000203 NP682354.RAm5hR2G67FpBGBoIJnKauL1O2-veAItRBgWM8YIMlVKE130_provenance.